Company: MYSEW
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001213900-25-110045
Chunk: 43

Company: Myseum, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1
Chunk 43
---
 years) 
     3.5 to 6 years 
  
    Volatility 
     164.0% to 189.1% 
  
    Risk—free interest rate 
     3.73% to 4.59% 

The following is a summary of the Company’s
stock option activity for the nine months ended September 30, 2025 as presented below:

     Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Contractual Life (Years)   Balance on December 31, 2024   114,570   $126.92    2.08   Granted   590,000    4.21    -     Cancelled   (12,750)   (34.07)   -     Balance on September 30, 2025   691,820   $23.94    5.95   Options exercisable on September 30, 2025   170,570   $84.76    4.32   Weighted average fair value of options granted during the 2025 period       $3.20       

On September 30, 2025, the aggregate intrinsic
value of options outstanding was $0.

Common Stock Warrants

On January 16, 2024, in connection with the Underwriting
Agreement, the Company sold pre-funded warrants to purchase up to 590,000 shares of Common Stock (the “Pre-Funded Warrants”).
The public offering price was $1.8499 for each Pre-Funded Warrant for aggregate gross proceeds of $1,091,441. The per share exercise
price for the Pre-Funded Warrants was $0.0001 and the Pre-Funded Warrants were exercisable immediately. The Underwriters immediately
exercised the 590,000 Pre-Funded Warrants and the Underwriters received 589,981 shares of Common Stock since the exercise was cashless.

21

MYSEUM, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2025 AND 2024

(Unaudited)

A summary of the Company’s outstanding stock
warrants, including 44,252 Series A public warrants, is presented below:

     Number of W